Penumbra, Inc. (PEN)
323.79
-1.39
(-0.43%)
USD |
NYSE |
Aug 24, 16:00
323.79
0.00 (0.00%)
After-Hours: 20:00
Penumbra Total Assets (Quarterly) : 1.975B for June 30, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 1.975B |
| March 31, 2026 | 1.898B |
| December 31, 2025 | 1.827B |
| September 30, 2025 | 1.744B |
| June 30, 2025 | 1.675B |
| March 31, 2025 | 1.593B |
| December 31, 2024 | 1.533B |
| September 30, 2024 | 1.479B |
| June 30, 2024 | 1.535B |
| March 31, 2024 | 1.580B |
| December 31, 2023 | 1.556B |
| September 30, 2023 | 1.468B |
| June 30, 2023 | 1.433B |
| March 31, 2023 | 1.395B |
| December 31, 2022 | 1.371B |
| September 30, 2022 | 1.322B |
| June 30, 2022 | 1.328B |
| March 31, 2022 | 1.302B |
| December 31, 2021 | 1.244B |
| September 30, 2021 | 973.24M |
| June 30, 2021 | 910.22M |
| March 31, 2021 | 840.82M |
| December 31, 2020 | 822.98M |
| Date | Value |
|---|---|
| September 30, 2020 | 810.30M |
| June 30, 2020 | 780.20M |
| March 31, 2020 | 664.24M |
| December 31, 2019 | 665.90M |
| September 30, 2019 | 614.17M |
| June 30, 2019 | 585.11M |
| March 31, 2019 | 568.79M |
| December 31, 2018 | 515.01M |
| September 30, 2018 | 501.00M |
| June 30, 2018 | 499.31M |
| March 31, 2018 | 489.71M |
| December 31, 2017 | 476.67M |
| September 30, 2017 | 459.09M |
| June 30, 2017 | 417.00M |
| March 31, 2017 | 418.36M |
| December 31, 2016 | 308.25M |
| September 30, 2016 | 297.28M |
| June 30, 2016 | 283.98M |
| March 31, 2016 | 275.12M |
| December 31, 2015 | 263.85M |
| September 30, 2015 | 259.35M |
| June 30, 2015 | 129.10M |
| March 31, 2015 | 127.45M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Boston Scientific Corp. | 45.22B |
| Globus Medical, Inc. | 5.488B |
| Abbott Laboratories | 109.22B |
| AngioDynamics, Inc. | 267.16M |
| Teleflex, Inc. | 6.787B |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 443.96M |
| Shareholders Equity (Quarterly) | 1.531B |
| Debt to Equity Ratio | 0.139 |
| Current Ratio | 5.750 |
| Net Debt Paydown Yield | 0.01% |